Literature DB >> 15165643

Sublingual lorazepam in the treatment of familial paroxysmal nonkinesigenic dyskinesia.

Joseph M Dooley1, Paula M Brna.   

Abstract

Familial paroxysmal nonkinesigenic dyskinesia (Mount and Reback syndrome) is characterized by episodes of dystonia and chorea, which are precipitated by fatigue, emotional stress, alcohol, or foods. We report two children from a large kindred with this condition who responded to sublingual lorazepam.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165643     DOI: 10.1016/j.pediatrneurol.2003.12.011

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

1.  Treatment of paroxysmal dyskinesias in children.

Authors:  Jonathan W Mink
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

2.  Paroxysmal dyskinesias.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.